Stay updated on UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial
Sign up to get notified when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.

Latest updates to the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page
- Check6 days agoChange DetectedA new history entry Revision: v3.3.2 was added and the previous entry Revision: v3.3.1 was removed from the Record History.SummaryDifference0.1%

- Check13 days agoChange DetectedA new revision entry v3.3.1 was added and the previous v3.2.0 entry removed from the record history. This update concerns versioning metadata and does not modify the study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoval of the site-wide notice about government funding and potential delays from the top of the page. The header no longer displays the warning previously shown about data currency and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check35 days agoChange DetectedThe new screenshot preserves the same version history entries and fields as the old one, with only layout tweaks. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference11%

- Check71 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UniCAR02-T Cells & TM123 Dose-escalating Clinical Trial page.